NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: 2018 Year-end Business Update, page-25

  1. 1,580 Posts.
    lightbulb Created with Sketch. 323
    Agreed. I'm only interest in the SP once Lanstead are done. CoIld be wrong but I feel they are keeping it down as it's in their interest. The SP only matters if your buying or selling, I'm doing neither so happy to just wait for the 2019 news flow. The only way we get a TO announcement is if management have agreed to it. They, and the informed Walker, have too much of this company for a TO to be hostile.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.